Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 199 results found. Search for [ bharat biotech's covaxin ]

Results 1 to 21 of 199
PB Jayakumar
February 24, 2021
Serum delivered 600,000 doses of Covishield vaccines from Pune to Accra in Ghana. The vaccines arrived on a flight from Mumbai, via Dubai, where the flight also collected a shipment of syringes from a Gavi-funded stockpile at UNICEF's regional supply hub


BusinessToday.In
February 19, 2021
As part of the review process, Dr Reddy's will present the safety profile of the phase 2 study, and interim data of the phase 3 study, which is expected to complete by 21st February 2021.


BusinessToday.In
February 19, 2021
\"The interim analysis report should be out in a week,\" Bhargava said on the clinical trials against the new variants.


BusinessToday.In
February 19, 2021
India's ambitious vaccination campaign which has already covered over 1 crore healthcare workers, aims to cover 30 crore people by August


BusinessToday.In
February 19, 2021
In this meeting, the NTAGI will review the World Health Organisation's (WHO) recommendation to extend the gap between two doses of the AstraZeneca- Oxford vaccine from 4 weeks to 8-12 weeks


BusinessToday.In
February 12, 2021
Chhattisgarh CM had raised two primary concerns regarding Covaxin -- inhibitions on incomplete trials and absence of \"expiration date\". Dr Vardhan says vaccine approved after due evaluation of pre-clinical and clinical trial data and that expiry date is mentioned on its label


Ashutosh Kumar
February 11, 2021
Going forward, the company's vaccine strategy includes blocking capacity with airlines for international freight forwarding, finalising warehousing plans keeping in mind the specific needs of Covid-19 vaccine storage


BusinessToday.In
February 4, 2021
The Union Health Ministry has claimed that India has become the fastest country in the world to reach the 4 million vaccination mark in 18 days


BusinessToday.In
February 1, 2021
The finance minister added that the government will also provide Rs 35,000 crore for coronavirus vaccination in 2021-22 and is committed to providing further support to eliminate COVID-19


Anwesha Madhukalya
February 1, 2021
Budget 2021: Even if the vaccine is considered at a discounted rate for everyone at Rs 220, the cost per person would come to be around Rs 440 as the vaccine would need to be administered in two doses


BusinessToday.In
January 31, 2021
Serum in its reply stated that both the companies operate in different product categories and there is no scope for confusion over the trademark


BusinessToday.In
January 30, 2021
Serum Institute of India CEO Adar Poonawalla said the company's tie-up with American vaccine developer Novavax has published 'excellent efficacy results'


BusinessToday.In
January 29, 2021
President Kovind said that Atmanirbhar Bharat is not just confined to manufacturing in India but is also aimed at enhancing the standard of living of every Indian. He said that India's goal of Atmanirbhar Bharat will be strengthened by self reliance in agriculture


BusinessToday.In
January 29, 2021
The vaccine wastage can be largely attributed to not enough volunteers turning up after the vaccine vials were opened, which need to be utilised in up to four hours


BusinessToday.In
January 27, 2021
Catch top stories from the world of business and economy with BusinessToday.In's Biz EOD report


Joe C Mathew
January 27, 2021
The sera collected from Covaxin recepients (showing 99.6 percent seroconversion following vaccination) neutralised the UK variants, ICMR said


PB Jayakumar
January 26, 2021
Both COVID-19 vaccines being administered in India's extensive vaccination programme - Serum-Oxford-AstraZeneca's Covishield and Bharat Biotech's Covaxin - have a very short shelf life of just six months


BusinessToday.In
January 25, 2021
In a letter to chief secretaries of all states and UT, Union Home Secretary Ajay Bhalla advised them to take penal action against those who are found to be involved in dissemination of wrong and ill-informed rumours regarding safety and immunogenicity of the COVID-19 vaccine candidates


BusinessToday.In
January 22, 2021
The survey also found that only 76 per cent of respondents were willing to take the COVID-19 jab and 21 per cent still doubts about the efficacy of the vaccines


BusinessToday.In
January 21, 2021
The blaze was reported at an under-construction building in the Manjri area of the city. The Serum Institute of India's plant is spread over 100 acres in Pune


PAGES 1 OF 10  12345